Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact

Citations to this article

The RNFT2/IL-3Rα axis regulates IL-3 signaling and innate immunity
Yao Tong, … , Yuan Liu, Bill B. Chen
Yao Tong, … , Yuan Liu, Bill B. Chen
Published January 28, 2020
Citation Information: JCI Insight. 2020;5(3):e133652. https://doi.org/10.1172/jci.insight.133652.
View: Text | PDF
Research Article Inflammation Pulmonology

The RNFT2/IL-3Rα axis regulates IL-3 signaling and innate immunity

  • Text
  • PDF
Abstract

Interleukin-3 (IL-3) receptor α (IL-3Rα) is the α subunit of the ligand-specific IL-3R and initiates intracellular signaling in response to IL-3. IL-3 amplifies proinflammatory signaling and cytokine storm in murine sepsis models. Here we found that RNFT2 (RING finger transmembrane-domain containing protein 2, also TMEM118), a previously uncharacterized RING finger ubiquitin E3 ligase, negatively regulated IL-3–dependent cellular responses through IL-3Rα ubiquitination and degradation in the proteasome. In vitro, IL-3 stimulation promoted IL-3Rα proteasomal degradation dependent on RNFT2, and we identified IL-3Rα lysine 357 as a ubiquitin acceptor site. We determined that LPS priming reduces RNFT2 abundance, extends IL-3Rα half-life, and sensitizes cells to the effects of IL-3, acting synergistically to increase proinflammatory signaling. In vivo, IL-3 synergized with LPS to exacerbate lung inflammation in LPS and Pseudomonas aeruginosa–challenged mice; conversely, IL-3 neutralization reduced LPS-induced lung injury. Further, RNFT2 overexpression reduced lung inflammation and injury, whereas Rnft2 knockdown exacerbated inflammatory responses in LPS-induced murine lung injury. Last, we examined RNFT2 and IL-3Rα in human lung explants from patients with cystic fibrosis and also showed that IL-3 is elevated in mechanically ventilated critically ill humans at risk for acute respiratory distress syndrome. These results identify RNFT2 as a negative regulator of IL-3Rα and show a potential role for the RNFT2/IL-3Rα/IL-3 axis in regulating innate immune responses in the lung.

Authors

Yao Tong, Travis B. Lear, John Evankovich, Yanwen Chen, James D. Londino, Michael M. Myerburg, Yingze Zhang, Iulia D. Popescu, John F. McDyer, Bryan J. McVerry, Karina C. Lockwood, Michael J. Jurczak, Yuan Liu, Bill B. Chen

×

Total citations by year

Year: 2025 2024 2023 2022 2021 Total
Citations: 1 5 2 4 6 18
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article (18)

Title and authors Publication Year
Silencing of RNFT2 suppresses cell proliferation and migration through mTORC1 signaling pathway in gastric cancer
Wang Y, Ma Q, Zhu Z, Sang H, Fan H, Li Z
Amino Acids 2025
Large-scale phenotyping of patients with long COVID post-hospitalization reveals mechanistic subtypes of disease
Liew F, Efstathiou C, Fontanella S, Richardson M, Saunders R, Swieboda D, Sidhu JK, Ascough S, Moore SC, Mohamed N, Nunag J, King C, Leavy OC, Elneima O, McAuley HJ, Shikotra A, Singapuri A, Sereno M, Harris VC, Houchen-Wolloff L, Greening NJ, Lone NI, Thorpe M, Thompson AA, Rowland-Jones SL, Docherty AB, Chalmers JD, Ho LP, Horsley A, Raman B, Poinasamy K, Marks M, Kon OM, Howard LS, Wootton DG, Quint JK, de Silva TI, Ho A, Chiu C, Harrison EM, Greenhalf W, Baillie JK, Semple MG, Turtle L, Evans RA, Wain LV, Brightling C, Thwaites RS, Openshaw PJ
Nature Immunology 2024
E3 ubiquitin ligase RNF128 negatively regulates the IL-3/STAT5 signaling pathway by facilitating K27-linked polyubiquitination of IL-3Rα.
Yu J, Li J, Shen A, Liu Z, He TS
Cell communication and signaling : CCS 2024
IL-3: key orchestrator of inflammation
Podolska MJ, Grützmann R, Pilarsky C, Bénard A
Frontiers in immunology 2024
Crosstalk of ubiquitin system and non-coding RNA in fibrosis
Zhang H, Zhou Y, Jiang C, Jian N, Wang J
International journal of biological sciences 2024
Gene Expression Dysregulation in Whole Blood of Patients with Clostridioides difficile Infection
Tsakiroglou M, Evans A, Doce-Carracedo A, Little M, Hornby R, Roberts P, Zhang E, Miyajima F, Pirmohamed M
International Journal of Molecular Sciences 2024
Comprehensive analysis of CPSF4-related alternative splice genes in hepatocellular carcinoma.
Yuemaierabola A, Guo J, Sun L, Yeerkenbieke B, Liu F, Ye D, Zhai X, Guo W, Cao Y
Journal of Cancer Research and Clinical Oncology 2023
Transcriptomes of human primary skin fibroblasts of healthy individuals reveal age‐associated mRNAs and long noncoding RNAs
Tsitsipatis D, Martindale JL, Mazan\u2010Mamczarz K, Herman AB, Piao Y, Banskota N, Yang J, Cui L, Anerillas C, Chang M, Kaileh M, Munk R, Yang X, Ubaida\u2010Mohien C, Chia CW, Karikkineth AC, Zukley L, D'Agostino J, Abdelmohsen K, Basisty N, De S, Ferrucci L, Gorospe M
Aging Cell 2023
MARCH3 negatively regulates IL-3-triggered inflammatory response by mediating K48-linked polyubiquitination and degradation of IL-3Rα
L Feng, C Li, L Zeng, D Gao, Y Sun, L Zhong, H Lin, H Shu, S Li
Signal Transduction and Targeted Therapy 2022
Distributed genetic architecture across the hippocampal formation implies common neuropathology across brain disorders
Bahrami S, Nordengen K, Shadrin AA, Frei O, van der Meer D, Dale AM, Westlye LT, Andreassen OA, Kaufmann T
Nature Communications 2022
N6-methyladenosine-related single-nucleotide polymorphism analyses identify oncogene RNFT2 in bladder cancer
Lv J, Song Q, Bai K, Han J, Yu H, Li K, Zhuang J, Yang X, Yang H, Lu Q
Cancer Cell International 2022
The role of the immune microenvironment in bone, cartilage, and soft tissue regeneration: from mechanism to therapeutic opportunity
Xiong Y, Mi BB, Lin Z, Hu YQ, Yu L, Zha KK, Panayi AC, Yu T, Chen L, Liu ZP, Patel A, Feng Q, Zhou SH, Liu GH
Military Medical Research 2022
The β3/5 Integrin-MMP9 Axis Regulates Pulmonary Inflammatory Response and Endothelial Leakage in Acute Lung Injury
Y Tong, C Bao, YQ Xu, L Tao, Y Zhou, L Zhuang, Y Meng, H Zhang, J Xue, W Wang, L Zhang, Q Pan, Z Shao, T Hu, Q Guo, Q Xue, H Lu, Y Luo
Journal of inflammation research 2021
Adipocyte-specific deletion of HuR induces spontaneous cardiac hypertrophy and fibrosis
AR Guarnieri, SR Anthony, A Gozdiff, LC Green, SM Fleifil, S Slone, ML Nieman, P Alam, JB Benoit, AP Owens, O Kanisicak, M Tranter
American journal of physiology. Heart and circulatory physiology 2021
Pet ownership in pregnancy and methylation pattern in cord blood
H Danielewicz, A Gurgul, A Dębińska, G Myszczyszyn, T Szmatoła, A Myszkal, I Jasielczuk, A Drabik-Chamerska, L Hirnle, A Boznański
Genes and Immunity 2021
Novel CD123 polyaptamer hydrogel edited by Cas9/sgRNA for AML-targeted therapy
H Wu, L Zhang, Z Zhu, C Ding, S Chen, R Liu, H Fan, Y Chen, H Li
Drug Delivery 2021
LOX-1-Expressing Immature Neutrophils Identify Critically-Ill COVID-19 Patients at Risk of Thrombotic Complications
B Combadière, L Adam, N Guillou, P Quentric, P Rosenbaum, K Dorgham, O Bonduelle, C Parizot, D Sauce, J Mayaux, CE Luyt, A Boissonnas, Z Amoura, V Pourcher, M Miyara, G Gorochov, A Guihot, C Combadière
Frontiers in immunology 2021
Pharmacogenetic studies of long-acting beta agonist and inhaled corticosteroid responsiveness in randomised controlled trials of individuals of African descent with asthma
V Ortega, M Daya, S Szefler, E Bleecker, V Chinchilli, W Phipatanakul, D Mauger, F Martinez, E Herrera-Luis, M Pino-Yanes, G Hawkins, E Ampleford, S Kunselman, C Cox, L Bacharier, M Cabana, J Cardet, M Castro, L Denlinger, C Eng, A Fitzpatrick, F Holguin, D Hu, D Jackson, N Jarjour, M Kraft, J Krishnan, S Lazarus, R Lemanske, J Lima, N Lugogo, A Mak, W Moore, E Naureckas, S Peters, J Pongracic, S Sajuthi, M Seibold, L Smith, J Solway, C Sorkness, S Wenzel, S White, E Burchard, K Barnes, D Meyers, E Israel, M Wechsler, T Ali-Dinar, L Bartnikas, S Baxi, A Beigelman, M Benson, K Blake, E Burke-Roberts, M Cernadas, J Chmiel, R Covar, E DiMango, J Gaffin, D Gentile, N Grossman, M Hautpman, D Kantor, H Kumar, C LaForce, J Lang, D Long, M Louisias, W Morgan, J Moy, R Myers, J Olin, P Permaul, L Que, H Raissy, R Robison, K Ross, W Sheehan, L Sullivan-Vedder, L Wright
The Lancet Child & Adolescent Health 2021

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts